Skip to main content
. 2022 Apr 25;10(3):e02694-21. doi: 10.1128/spectrum.02694-21

TABLE 1.

Susceptibility testing results for the isolates based on various antibiotics on the AST-GN83 card

Drug No. of isolatesa
Acinetobacter spp.
Aeromonas spp.
Enterobacter spp.
K. pneumoniae
Proteus spp.
Providencia spp.
Pseudomonas spp.
S. paucimobilis
S R S R S R S R S R S R S R S R
AMP 0 1 0 21 1 3 0 3
AMC 22 5 0 17 17 4 4 0
AMS 3 1 1 26 16 5 3 1 3 0
TZP 3 0 24 3 17 0 21 0 4 0 3 0 9 0 15 0
CFZ 1 3 7 20 0 17 16 5 3 1 0 3 1 8 19 0
CFE 26 1 1 16 18 3 3 1 2 1
CFN 10 17 0 17 17 4 3 1 2 1
CEFO 4 0 1 0 17 0 18 3 4 0 3 0 7 2 19 0
CEFZ 4 0 26 1 17 0 18 3 4 0 3 0 9 0 16 2
CEFX 4 0 1 0 17 0 18 3 4 0 3 0 8 0 19 0
CEFE 4 0 26 1 17 0 18 3 4 0 3 0 9 0 19 0
ATM 1 0 17 0 18 3 4 0 3 0 9 9
MER 4 0 1 0 17 0 21 0 4 0 3 0 9 0 19 0
AMI 2 0 27 0 17 0 21 0 4 0 3 0 9 0 19 0
GEN 4 0 27 0 16 1 20 1 3 1 3 0 9 0 19 0
CIP 3 1 26 1 17 0 18 3 3 1 3 0 8 1 18 1
NIT 0 1 14 3 15 6 1 3 0 3 0 1
TMP 3 0 16 11 9 8 10 11 0 4 2 1 3 5 16 2
a

S, susceptible; R, resistant; —, not available; AMP, ampicillin; AMC, amoxicillin-clavulanic acid; AMS, ampicillin-sulbactam; TZP, piperacillin-tazobactam; CFZ, cefazolin; CFE, cefuroxime; CFN, cefoxitin; CEFO, cefotaxime; CEFZ, ceftazidime; CEFX, ceftriaxone; CEFE, cefepime; ATM, aztreonam; MER, meropenem; AMI, amikacin; GEN, gentamicin; CIP, ciprofloxacin; NIT, nitrofurantoin; TMP, trimethoprim-sulfamethoxazole.